Alzheimer’s Disease/Dementia News

History of stroke was associated with increased odds of cognitive impairment in both non-Hispanic white and Mexican American individuals, researchers reported.

Aptinyx Inc. announced it has completed enrollment in the company’s ongoing phase 2 study of NYX-458, an oral treatment for cognitive impairment associated with Parkinson’s disease and dementia with Lewy bodies.

Alpha Cognition Inc. has announced positive results from a bioequivalence study with Alpha-1062, a proprietary, delayed release oral tablet formulation in development for the treatment of mild to moderate Alzheimer’s disease.

Being overweight was negatively associated with the incidence of dementia in women in Germany, while being underweight was linked to dementia in men, researchers reported in the Journal of Alzheimer’s Disease.

Researchers at Invicro have found evidence supporting cellular stress and bioenergetic abnormalities in patients with early-stage Alzheimer's disease, according to new data published in Science Translational Medicine.

SYNAPS Dx has announced the opening of a new laboratory to support the launch of DISCERN, a minimally invasive diagnostic test to identify Alzheimer’s disease in people with dementia.

Leisure activities, such as reading a book, doing yoga and spending time with family and friends, were associated with a decreased risk for all-cause dementia, Alzheimer's disease and vascular dementia, researchers reported in Neurology.

SAN DIEGO — In older adult patients with Alzheimer’s-related dementia, treatment with brexpiprazole resulted in greater reduction in agitation compared with placebo, while proving to be safe and well-tolerated.

The University of New Hampshire announced it will receive a 5-year, $2.8 million grant from NIH to develop and test social assistive robots to elevate at-home care for people with Alzheimer’s disease and dementia.

Atrial cardiopathy was associated with increased risk for dementia, according to new data from the ARIC cohort study.